UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in BEAM — Beam Therapeutics Inc.
CIK 861177
NEW YORK, NY
Position in BEAM
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$53,257,120
+$13,849,119 QoQ
Shares Held
1,551,781
-6.2% QoQ
Ownership
1.50%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#17
of 274 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 39%
Shared 0%
None 61%
Common Shares in BEAM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. BEAM ranks #18 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in BEAM
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $53,257,120 | 1,551,781 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $39,408,001 | 1,653,714 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $47,466,588 | 1,712,359 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $40,418,891 | 1,665,385 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,392,867 | 493,408 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,564,469 | 438,529 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $9,818,814 | 395,920 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $9,831,505 | 401,286 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $9,830,497 | 419,569 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $9,857,348 | 298,346 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $8,321,994 | 305,731 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $6,737,726 | 280,155 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $7,536,212 | 236,023 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $7,227,023 | 236,023 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $9,718,949 | 248,503 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,800,752 | 58,790 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,530,392 | 65,368 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,565,720 | 44,777 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,224,255 | 40,460 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,449,073 | 39,640 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,858,029 | 37,744 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,452,805 | 18,151 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,064,422 | 13,038 | Shares | Defined | 2021-03-01 | |
| No filing history on record for this holder in this stock. | ||||||